ILIEV ILIYAN DIMITROV

Interdisciplinary Cluster for Cutting Edge Research Institute for Biomedical Sciences 

Professor 

Researcher Information

Degree

  • Ph.D., University of Milan (Italy)

Career

  • 2020
    Visiting Professor (specially appointed), Institute for Biomedical Sciences, Shinshu University, Nagano, Japan
  • 2020
    Associate Professor of Immunology in Medicine Weill Cornell Medicine, New York, NY
  • 2019
    Co-director, the Microbiome Core Lab at The Jill Roberts Institute, Weill Cornell Medicine, NYC
Research activity information

Award

  • 2020
    Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease
  • 2019
    Young Investigator Award, Weill Cornell Medicine, NYC
  • 2018
    Society for Mucosal Immunology: Board of Councilors YP member
  • 2018
    Irma T. Hirschl Scholar
  • 2016
    Kenneth Rainin Foundation Breakthrough Award
  • 2015
    Kenneth Rainin Foundation Innovator Award
  • 2014
    K99 Career Development Award (DK09831) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • 2012
    UCLA Clinical and Translational Science Institute (CTSI) Publication Award, Los Angeles, CA
  • 2012
    Presentation Award at RCAI International Summer Program, RIKEN Research Centre for Allergy and Immunology, Yokohama, Japan
  • 2010
    Malaniak Award for Excellence in Postdoctoral Research, Cedars-Sinai Medical Center, Los Angeles, CA
  • 2008
    Travel Award from the Federation of Clinical Immunology Societies (FOCIS) at FOCIS 2008 Annual Meeting, Boston, USA
  • 2007
    Travel Award from the Federation of Clinical Immunology Societies (FOCIS) at FOCIS 2007 Annual Meeting, San Diego, USA
  • 2006
    Days of Molecular Medicine (DDM) award - Nobel Forum, Stockholm, Sweden
  • 2006
    Presentation Award at the 4th International Meeting on Inflammatory Bowel Diseases, Capri, Italy

Paper

  • The future of fungi: threats and opportunities.
    Case NT, Berman J, Blehert DS, Cramer RA, Cuomo C, Currie CR, Ene IV, Fisher MC, Fritz-Laylin LK, Gerstein AC, N Glass L, Gow NAR, Gurr SJ, Hittinger CTodd, Hohl TM, Iliev ID, James TY, Jin H, Klein BS, Kronstad JW, Lorch JM, McGovern V, Mitchell AP, Segre JA, Shapiro RS, Sheppard DC, Sil A, Stajich JE, Stukenbrock EE, Taylor JW, Thompson D, Wright GD, Heitman J, Cowen LE.
    G3 (Bethesda), 12(11), jkac224, 2022
  • Immune regulation by fungal strain diversity in inflammatory bowel disease.
    Li XV, Leonardi I, Putzel GG, Semon A, Fiers WD, Kusakabe T, Lin W-Y, Gao IH, Doron I, Gutierrez-Guerrero A, DeCelie MB, Carriche GM, Mesko M, Yang C, Naglik JR, Hube B, Scherl EJ, Iliev ID.
    Nature, 603(7902), 672-678, 2022
  • Mucosal fungi promote gut barrier function and social behavior via Type 17 immunity.
    Leonardi I, Gao IH, Lin W-Y, Allen M, Li XV, Fiers WD, De Celie MBialt, Putzel GG, Yantiss RK, Johncilla M, Colak D, Iliev ID.
    Cell, 185(5), 831-846.e14, 2022
  • Human gut mycobiota tune immunity via CARD9-dependent induction of anti-fungal IgG antibodies
    Doron I, Leonardi I, Li XV, Fiers WD, Semon A, Bialt-DeCelie M, Migaud M, Gao IH, Lin WY, Kusakabe T, Puel A, Iliev ID
    Cell, 18;184(4), 1017-1031.e14, 2021
  • Effects of Intestinal Fungi and Viruses on Immune Responses and Inflammatory Bowel Diseases
    Iliev, ID and Cadwell, K
    GASTROENTEROLOGY, 160(4), 1055-1066, 2021
  • Voices of biotech research,
    Annabi N, Baker M, Boettiger A, Chakraborty D, Chen Y, Corbett KS, Correia B, Dahlman J, de Oliveira T, Ertuerk A, Yanik MF, Henaff E, Huch M, Iliev ID, Jacobs T, Junca H, Keung A, Kolodkin-Gal I, Krishnaswamy S, Lancaster M, Macosko E, Martínez-Núñez MA, Miura K, Molloy J, Cruz AO, Platt RJ, Posey AD Jr, Shao H, Simunovic M, Slavov N, Takebe T, Vandenberghe LH, Varshney RK, Wang J.
    Nature Biotechnol, 39(3), 281-286, 2021
  • The cancer microbiome atlas: a pan-cancer comparative analysis to distinguish tissue-resident microbiota from contaminants.
    Dohlman AB, Arguijo Mendoza D, Ding S, Gao M, Dressman H, Iliev ID, Lipkin SM, Shen X.
    Cell Host Microbe, 10;29(2), 281-298.e5, 2021
  • Macrophages Maintain Epithelium Integrity by Limiting Fungal Product Absorption
    Chikina AS, Nadalin F, Maurin M, San-Roman M, Thomas-Bonafos T, Li XV, Lameiras S, Baulande S, Henri S, Malissen B, Lacerda Mariano L, Barbazan J, Blander JM, Iliev ID, Matic Vignjevic D, Lennon-Duménil AM.
    Cell, 183(2), 411-428.e16, 2020
  • Fungal Trans-kingdom Dynamics Linked to Responsiveness to Fecal Microbiota Transplantation (FMT) Therapy in Ulcerative Colitis,
    Leonardi I., Paramsothy S, Doron I, Semon A, Kaakoush NO, Clemente JC, Faith JJ, Borody TJ, Mitchell HM, Colombel JF, Kamm MA, Iliev ID.
    Cell Host & Microbe, 27(5), 823-829.e3, 2020
  • From Birth and Throughout Life: Fungal Microbiota in Nutrition and Metabolic Health
    Fiers WD, Leonardi I, Iliev ID
    Annual Review of Nutrition, 2020電子ジャーナル
  • Gut mycobiota under scrutinity: fungal symbionts or environmental transients?
    Fiers W. Gao I., Iliev ID.
    Current Opinion in Microbiology, 50, 79-86, 2019
  • Modulation of the fungal mycobiome is regulated by the chitin-binding receptor FIBCD1.
    Moeller JB, Leonardi I, Schlosser A, Flamar AL, Bessman NJ, Putzel GG, Thomsen T, Hammond M, Jepsen CS, Skjødt K, Füchtbauer EM, Farber DL, Sorensen GL, Iliev ID, Holmskov U, Artis D
    J Exp Med., em.20182244, 2019
  • Laboratory mice born to wild mice have natural microbiota and model human immune responses.
    Rosshart SP, Herz J, Vassallo BG, Hunter A, Wall MK, Badger JH, McCulloch JA, Anastasakis DG, Sarshad AA, Leonardi I, Collins N, Blatter JA, Han SJ, Tamoutounour S, Potapova S, Foster St Claire MB, Yuan W, Sen SK, Dreier MS, Hild B, Hafner M, Wang D, Iliev ID, Belkaid Y, Trinchieri G, Rehermann B.
    Science., 365(6452), 2019
  • Gut Mycobiota in Immunity and Inflammatory Disease,
    Li XV, Leonardi I, Iliev ID.,
    Immunity, 50(6), 1365-1379, 2019
  • Endocytosis of commensal antigens by intestinal epithelial cells regulates mucosal T cell homeostasis.
    Ladinsky MS, Araujo LP, Zhang X, Veltri J, Galan-Diez M, Soualhi S, Lee C, Irie K, Pinker EY, Narushima S, Bandyopadhyay S, Nagayama M, Elhenawy W, Coombes BK, Ferraris RP, Honda K, Iliev ID, Gao N, Bjorkman PJ, Ivanov II.
    Science., 363(6431), 2019
  • Profound mycobiome differences between segregated mouse colonies do not influence Th17 responses to a newly introduced gut fungal commensal.
    Doron I, Leonardi I, Iliev ID.
    Fungal Genet Biol.,, 127, 45-49, 2019
  • Malassezia Is Associated with Crohn's Disease and Exacerbates Colitis in Mouse Models.
    Limon JJ, Tang J, Li D, Wolf AJ, Michelsen KS, Funari V, Gargus M, Nguyen C, Sharma P, Maymi VI, Iliev ID, Skalski JH, Brown J, Landers C, Borneman J, Braun J, Targan SR, McGovern DPB, Underhill DM.
    Cell Host & Microbe., 25(3), 377-388.e6, 2019
  • Response to Fungal Dysbiosis by Gut Resident CX3CR1+ Mononuclear Phagocytes Aggravates Allergic Airway Disease.
    Li, X., Leonardi, I. , Semon, A. , Doron, I., Gao, H. , Putzel, H., Kim Y., Kabata H., Artis D., Fiers W., Ramer-Tait A., Iliev I.D.,
    Cell Host & Microbe., 24(6), 847-586, 2018
  • Macrophage interactions with fungi and bacteria in inflammatory bowel disease.
    Leonardi I, Li X, Iliev ID.
    Curr Opin Gastroenterol., 34(6), 392-397, 2018
  • Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1-infected individuals.
    Uzzan M, Tokuyama M, Rosenstein AK, Tomescu C, SahBandar IN, Ko HM, Leyre L, Chokola A, Kaplan-Lewis E, Rodriguez G, Seki A, Corley MJ, Aberg J, La Porte A, Park EY, Ueno H, Oikonomou I, Doron I, Iliev ID, Chen BK, Lui J, Schacker TW, Furtado GC, Lira SA, Colombel JF, Horowitz A, Lim JK, Chomont N, Rahman AH, Montaner LJ, Ndhlovu LC, Mehandru S.
    SCIENCE TRANSLATIONAL MEDICINE, 10, eaau4711., 2018
  • CX3CR1+ mononuclear phagocytes control immunity to intestinal fungi.
    Leonardi I, Li X, Semon A, Li D, Doron I, Putzel G, Bar A, Prieto D, Rescigno M, McGovern DPB, Pla J, Iliev ID
    Science., 359(6372), 232-236, 2018
  • Innate detection of microbial viability signals T follicular helper cell differentiation and antibody responses.
    Barbet, G.S., L. E.; Geswell, M; Leonardi, I.; Cerutti, A; Iliev, I.; Blander, J. M.
    Immunity, 48(3), 584-598, 2018
  • Fungal dysbiosis: immunity and interactions at mucosal barriers.
    Iliev ID. and Leonardi I.
    Nat. Rev. Immunology, 17(10), 635-646, 2017
  • Candidalysin sets off the innate alarm.
    Li, X, Leonardi I, Iliev ID.
    Science Immunol., 2, eaao5703, 2017
  • Regulation of inflammation by microbiota interactions with the host.
    Blander JM, Longman RS, Iliev ID, Sonnenberg GF, Artis D.
    Nat Immunol., 19;18(8), 851-860, 2017
  • Immunity against fungi.
    Lionakis MS, Iliev ID, Hohl TM.
    JCI Insight., 2(11::), 2017
  • Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
    Jacob V, Crawford C, Cohen-Mekelburg S, Viladomiu M, Putzel GG, Schneider Y, Chabouni F, OʼNeil S, Bosworth B, Woo V, Ajami NJ, Petrosino JF, Gerardin Y, Kassam Z, Smith M, Iliev ID, Sonnenberg GF, Artis D, Scherl E, Longman RS
    Inflamm Bowel Dis, 23(6), 903-911, 2017
  • Immunological Consequences of Intestinal Fungal Dysbiosis.
    Wheeler ML, Limon JJ, Agnieszka SB, Leal CA, Gargus M, Tang J, Brown J, Funari VA, Wang HL, Crother T, Arditi M, Underhill DM, Iliev ID.
    Cell Host & Microbe, 19(6), 865-873, 2016
  • Dectin-1 Exerts Dual Control in the Gut.
    Iliev ID.
    Cell Host & Microbe, 12;18(2), 139-141, 2015
  • Poorly Cross-Linked Peptidoglycan in MRSA Due to mecA Induction Activates the Inflammasome and Exacerbates Immunopathology.
    Müller S, Wolf AJ, Iliev ID, Berg BL, Underhill DM, Liu GY.
    Cell Host & Microbe, 18(5), 604-612, 2015
  • Mycobiome: Approaches to Analysis of Intestinal Fungi.
    Tang J, Iliev ID, Brown J, Underhill DM, Funari VA.
    Journal of Immunological Methods,, 421, 112-121, 2015
  • The development of innate lymphoid cells requires TOX-dependent generation of a common innate lymphoid cell progenitor.
    Seehus CR, Aliahmad P, de la Torre B, Iliev ID, Spurka L, Funari VA, Kaye J
    Nature Immunol, 16(6), 599-608, 2015
  • HAEC Collaborative Research Group (HCRG). Characterization of Bacterial and Fungal Microbiome in Children with Hirschsprung Disease with and without a History of Enterocolitis: A Multicenter Study.
    Frykman PK, Nordenskjöld A, Kawaguchi A, Hui TT, Granström AL, Cheng Z, Tang J, Underhill DM, Iliev ID, Funari VA, Wester T
    PLOS ONE, 24;10(4), e0124172., 2015
  • The mycobiota: interactions between commensal fungi and the host immune system.
    Underhill DM and Iliev ID,
    Nature Reviews Immunology, 14(6), 405-416, 2014
  • Striking a balance: fungal commensalism versus pathogenesis.
    Iliev ID and Underhill DM
    Current Opinion in Microbiology, 16(3), 366-373, 2013
  • Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis.
    Iliev ID, Funari VA, Taylor KD, Nguyen Q, Reyes CN, Strom SP, Brown J, Becker CA, Fleshner PR, Dubinsky M, Rotter JI, Wang HL, McGovern DPB, Brown GD, Underhill DM,
    science, 336(6086), 1314-1317, 2012
  • Dendritic cells produce TSLP that limits the differentiation of Th17 cells, fosters Treg development, and protects against colitis.
    Spadoni I., Iliev ID, Rossi G., Rescigno M.
    Mucosal Immunol., 5(2), 184-193, 2012
  • Gut CD103+ dendritic cell expressed indoleamine 2,3-dioxygenase influences T regulatory/Th effector cell balance and oral tolerance in mice.
    Matteoli G, Mazzini E, Iliev ID, Mileti E, Fallarino F.,Puccetti P, Chieppa M., Rescigno M.
    Gut, 59(5), 595-604, 2010
  • Inactivation of junctional adhesion molecule-A enhances antitumoral immune response by promoting dendritic cell and T lymphocyte infiltration.
    Murakami M., Francavilla C.,Torselli I., Maddaluno L., Sica A, Matteoli G., Iliev ID, Mantovani A.,Rescigno M.,Cavallaro U., Dejana E.
    Cancer Research., 70(5), 1759-1765, 2010
  • Interleukin-23: linking mesenteric lymph node dendritic cells with Th1 immunity in Crohn's disease.
    Rescigno M and Iliev ID,
    Gastroenterology., 137(5), 1566-1570, 2009
  • Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells,
    Iliev ID, Spadoni I, Mileti E, Matteoli G, Sonzogni A, Sampietro GM, Foschi D, Caprioli F, Viale G, Rescigno M.
    Gut., 58(11), 1481-1489, 2009
  • Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy.
    Mileti E, Matteoli G, Iliev ID, Rescigno M.
    PLoS One., 4(9), e7056, 2009
  • Intestinal epithelial cells promote colitis-protective regulatory T cell differentiation through dendritic cell conditioning,
    Iliev ID, Mileti E., Matteoli G, Chieppa M., and Rescigno M.
    Mucosal Immunol., 2(4), 340-350, 2009
  • Immunostimulatory Oligodeoxynucleotide Containing TTTCGTTT Motif from Lactobacillus rhamnosus GG DNA Potentially Suppresses OVA-specific IgE Production in Mice,
    Iliev ID, Tohno M., Kurosaki D., Shimosato T., He F., Hosoda M., Saito T. and Kitazawa H.
    Scand J Immunol., 67(4), 370-376, 2008
  • The yin and yang of intestinal epithelial cells in controlling dendritic cell function,
    Iliev ID, Matteoli G and Rescigno M.
    J Exp Med, 204(10), 2253-2257, 2007
  • Strong immunostimulatory activity of AT-oligodeoxynucleotide requires a six-base loop with a self-stabilized 5'-C G-3' stem structure.
    Shimosato T., Kimura T., Tohno M., Iliev ID, Katoh S., Itoh Y., Kawai Y., Sasaki T., Saito T., Kitazawa H.
    Cellular Microbiology., 8(3), 485-495, 2006
  • Strong immunostimulation in murine immune cells by Lactobacillus rhamnosus GG DNA containing novel oligodeoxynucleotide pattern,
    Iliev ID, Kitazawa H., Shimosato T., Katoh S., Morita H., He F., Hosoda M. and Saito T.
    Cellular Microbiology,, 7(3), 403-414, 2005
  • Augmentation of TH-1 type response by immunoactive AT oligonucleotide from lactic acid bacteria via Toll-like receptor 9 signaling.
    Shimosato, T., H. Kitazawa, S. Katoh, M. Tohno, Iliev ID, C. Nagasawa, T. Kimura, Y. Kawai, T. Saito.
    Biochem. Biophys. Res. Commun., 326, 782-787, 2005
  • Toll-like receptor 2 is expressed on the intestinal M cells in swine.
    Tohno M., Shimosato T., Kitazawa H., Katoh S., Iliev ID, Kimura T., Kawai Y., Watanabe K., Aso H., Yamaguchi T., Saito T.
    Biochem. Biophys. Res. Commun,, 330, 547-554, 2005

Lectures, oral presentations, etc.

  • Invited speaker, ISAPP International Association Mycobiome symposium, USA (virtual seminar)
    Jul. 2021
  • Invited speaker, Vision 2030: Changing Paradigms in Inflammatory Bowel Diseases, Berlin, Germany (moved to virtual)
    Jun. 2021
  • Invited speaker, American Association of Immunology AAI 104th annual meeting, USA (virtual seminar)
    May 2021
  • Invited speaker, M Y C OT A L K S, Hosted by MRC CMM University of Exeter, UK
    Apr. 2021
  • Invited speaker, CIFAR Fungal Kingdom: Threats & Opportunities virtual meeting, CIFAR Global Program, Toronto, Canada (virtual seminar)
    Mar. 2021
  • Virtual seminar, DDRCC seminar series, Medical University of South Carolina, USA
    Mar. 2021
  • Invited speaker, 10th Annual Fox Chase Inflammation Signaling Symposium, Fox Chase Cancer Center, PA, USA
    Oct. 2020
  • Invited talk, EMBO | EMBL Symposium: Innate Immunity in Host-Pathogen Interactions, EMBL Heidelberg, Germany *Interrupted due to the pandemic
    Jun. 2020
  • Keynote Speaker, Joint PhD programs retreat, “Tissue Home and Inflammation and Immunity”, Medical University of Vienna, Vienna, Austria *Interrupted due to the pandemic
    May 2020
  • Invited talk, Dartmouth College, Geisel School of Medicine, USA *Interrupted due to the pandemic
    Apr. 2020
  • Invited talk, American Association for Cancer Research (AACR) Annual Meeting, San Diego, USA *Interrupted due to the pandemic
    Apr. 2020
  • Plenary talk, Microbiota MI meeting, Milan, Italy
    Feb. 2020
  • Invited talk, Crohn and Colitis Foundation annual meeting, Austin, USA
    Jan. 2020
  • Plenary talk, 48th annual meeting of the Japanese Society for Immunology, Hamamatsu, Japan
    Dec. 2019
  • Invited talk, Tokyo University, Immunology Seminar Series, Tokyo, Japan
    Dec. 2019
  • Invited talk, Department of Health, Wadsworth Center, Seminar Series, Albany, USA
    Dec. 2019
  • Invited talk, Molecular Microbiology & Immunology Seminars, Brown University, Providence, USA
    Nov. 2019
  • Plenary talk, Rustbelt Microbiome conference, Pittsburgh, USA
    Nov. 2019
  • Invited talk, 3rd Annual National Heart and Lung Institute Meeting, New York, USA
    Oct. 2019
  • Invited talk, FOCIS 2019, Boston, USA
    Jun. 2019
  • Grand Rounds Talk, WCM Department of Medicine, New York, USA
    Jun. 2019
  • Invited talk, Digestive Diseases Week, DDW 2019, San Diego, USA
    May 2019
  • Invited talk, Nature Biotechnology NYC SciCafe, NYC
    May 2019
  • Invited talk, Center for Immunity and Inflammation Seminar Series, Rutgers University, NYC, USA
    Mar. 2019
  • Invited talk, Immunology Club Seminar Series, NYU School of Medicine, NYC, USA
    Mar. 2019
  • AbbVie, Boston, USA
    Feb. 2019
  • Keynote Speaker: Gordon Research Conference “Mechanisms of Fungal Immunopathology” Galveston, TX, USA
    Jan. 2019
  • Invited talk, IEO Alumni Meeting, IFOM-IEO Campus, Milan, Italy
    Dec. 2018
  • Invited talk, Global Health and Emerging Pathogens Institute Seminar Series, Icahn School of Medicine, Mount Sinai, NYC, USA
    Dec. 2018
  • Plenary talk, Beneficial Microbes meeting, Amsterdam, Netherlands
    Nov. 2018
  • Invited talk, Immunology seminar series, University of Chicago, USA
    Nov. 2018
  • Invited talk, Mucosal Immunity Symposium, Merck Research Laboratories, Boston, USA
    Nov. 2018
  • Invited talk, Massachusetts General Hospital, Boston, USA
    Oct. 2018
  • Plenary talk, The European Academy of Allergy and Clinical Immunology Annual Congress (EAACI 2018), Munich, Germany
    May 2018
  • Invited talk, KU Leuven, Leuven, Belgium
    May 2018
  • Plenary talk, American Society for Microbiology Conference on Candida and Candidiasis, Providence, RI, USA
    Apr. 2018
  • Seminar series, Genentech, South San Francisco, CA, USA
    Apr. 2018
  • Plenary talk, North American Microbiome Congress, San Diego, USA
    Feb. 2018
  • Invited talk, Division of Gastroenterology Grand Rounds, Mount Sinai, New York, USA
    Jan. 2018
  • Invited talk, Keio University, Tokyo, Japan
    Nov. 2017
  • Invited talk, Shinshu University, Nagano, Japan
    Nov. 2017
  • Invited talk, NYC IBD Research Day, Rockefeller University, New York, USA
    Nov. 2017
  • Keynote speaker at the joint PhD program retreat- Open University, UK and SEMM Milan, Italy
    Oct. 2017
  • Invited talk: Fifth Annual Pediatric IBD Research Day, Weill Cornell Medicine, New York
    Oct. 2017
  • Plenary talk, Microbiome Bootcamp, University of Pittsburgh, USA
    Sep. 2017
  • Plenary talk, Kenneth Rainin Innovation Symposium, San Francisco, USA
    Jul. 2017
  • Invited talk, International Congress of Mucosal Immunology ICMI 2017, Washington D.C., USA
    Jul. 2017
  • Plenary talk, FASEB Science Research Conference for Autoimmunity, Saxons River, Vermont, USA
    Jul. 2017
  • Invited talk, ASM Microbe 2017, New Orleans, Louisiana, USA
    Jun. 2017
  • Invited talk, Digestive Disease Week 2017, Chicago, Illinois, USA
    May 2017
  • Invited talk, 29th Fungal Genetics Conference, Asilomar, CA, USA
    Mar. 2017
  • Invited talk, Gordon Research Conference “Immunology of Fungal Infections,” Galveston, TX, USA
    Jan. 2017
  • Invited talk, Cytokines 2016, San Francisco, CA, USA
    Oct. 2016
  • Invited talk, 2016 Innovations Symposium, San Francisco, CA, USA
    Jul. 2016
  • Invited talk, “The non-bacterial gut microbiome, is it relevant to IBD?,” at the Asia America Assembly of IBD 2016, Beijing, China
    Apr. 2016
  • Invited talk , European Respiratory Society “Challenges in Respiratory Medicine” meeting, Jongny, Switzerland
    Feb. 2016
  • Invited talk, Infectious Disease Week 2015, San Diego, CA, USA
    Oct. 2015
  • Invited talk, The University of Pennsylvania, Philadephia, PA, USA
    Jun. 2015
  • Invited talk, American Thoracic Society (ATS 2015) Congress, Understanding the Lung Microbiome: Current State and Clinical Implications, Denver, CO, USA
    May 2015
  • Invited talk, University of Colorado Denver, Denver, CO USA
    May 2015
  • Invited talk , Children's Hospital Los Angeles, Los Angeles, CA, USA
    Mar. 2015
  • Invited talk, The Microbiome and Autoimmune Disease Colloquium, Leesburg, VA, USA
    May 2014
  • University of British Columbia, Vancouver, Canada
    Apr. 2014
  • Invited talk, Children's Hospital Los Angeles, Los Angeles, CA, USA
    Apr. 2014
  • Selected talk, Advances in Inflammatory Bowel Diseases meeting, Hollywood, FL, USA
    Dec. 2013
  • Invited talk, Medical University of South Carolina, Charleston, SC, USA
    Nov. 2013
  • Plenary talk, The Microbiome/Microbiota R&D and Business Collaboration Forum, San Diego, CA, USA
    Oct. 2013
  • Invited talk, The University of Southern California, Los Angeles, CA, USA
    Sep. 2013
  • Selected talk, 15th International Congress of Immunology, Milan, Italy
    Aug. 2013
  • Selected talk, The 16th International Congress of Mucosal Immunology, Vancouver, Canada
    Jul. 2013
  • Selected talk, Advances in Inflammatory Bowel Diseases meeting, Hollywood, FL, USA
    Dec. 2012
  • Invited talk, Genentech, South San Francisco, CA, USA
    Nov. 2012
  • RCAI International Summer Program, RIKEN Research Centre for Allergy and Immunology, Yokohama, Japan
    Jun. 2012
  • Selected talk, Immunology LA meeting, Los Angeles, CA, USA
    May 2012
  • Selected talk, Innate Immunity: Sensing the Microbes and Damage Signals International meeting, Keystone, CO, USA
    Mar. 2012
  • Selected talk, 15th International Congress of Mucosal Immunology, Paris, France
    Aug. 2011
  • Plenary talk, 14th International Congress of Immunology, Kobe, Japan
    Aug. 2010
  • Invited talk, Nestle Research Center, Lausanne, Switzerland
    Nov. 2008
  • Selected talk, European Mucosal Immunology Group (EMIG) Meeting, Milan, Italy
    Oct. 2008
  • Selected talk, Federation of Clinical Immunology Societies (FOCIS) Annual Meeting, Boston, MA, USA
    Jun. 2008
  • Plenary talk, TNO Beneficial Microbes Conference, Amsterdam, the Netherlands
    May 2008
  • The European Molecular Biology Laboratory (EMBO), Heidelberg, Germany
    Nov. 2007
  • Selected talk, Federation of Clinical Immunology Societies (FOCIS) Annual Meeting, San Diego, CA, USA
    Jun. 2007
  • Selected talk, 4th International Meeting on Inflammatory Bowel Diseases, Capri, Italy
    May 2006

Affiliated academic society

  • 2021
    Member of the American Association of Immunologists
  • 2010
    Member of the Society for Mucosal Immunology

Research Themes

  • Intestinal Fungal Communities (Mycobiota) in Mucosal Immunity and Disease